| Literature DB >> 29677532 |
Xiqing Li1, Zunlan Zhao2, Ming Li3, Mingyue Liu4, Andres Bahena2, Yaping Zhang5, Yuwei Zhang4, Chetan Nambiar2, Guangzhi Liu6.
Abstract
Sulforaphane (SF) exhibits an anti-tumor effect in a variety of cancers, but little is known about its function in nasopharyngeal carcinoma. SF could decrease the expression of stem cell markers, β-catenin, Nanog, c-Myc, Oct3/4 and Sox2 in nasopharyngeal cancer cells (HONE1 and SUN1), and inhibit the formation of tumor spheres. Moreover, SF inhibits proliferation and induces apoptosis decreasing the stemness of nasopharyngeal cancer cells through a mechanism related to STAT3 signaling in vitro. We found that SF inhibits total STAT3 expression level and STAT3 phosphorylation (troy 704 and troy 705) by upregulation of miRNA-124-3p. Our results provide the evidence for discovering the novel drugs against nasopharyngeal carcinoma, and potential drugs targeting STAT3 signaling pathway.Entities:
Keywords: Nasopharyngeal Cancer; STAT signal; Self-renewal; Sulforaphane; miRNA-124-3p
Mesh:
Substances:
Year: 2018 PMID: 29677532 DOI: 10.1016/j.biopha.2018.03.121
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529